PIONEERING bio-medical company Ai2, which is developing products to tackle infections, has secured £1.75m from institutional investors to continue developing its technology.

The company, a University of Manchester spin out, has received £950,000 from existing investor MTI Partners and £800,000 from SPARK Impact, the Liverpool-based manager for the North West Fund for Biomedical.

Based at the University of Manchester's Stopford Building on Oxford Road, Ai2 was incorporated in 2005 to commercialise re......for the full story register now for free or login below...